# Study on the Treatment of Anal Fistulas Using Alofisel Versus Fat Autologous Stem Cells

> **NCT05974280** · — · RECRUITING · sponsor: **Nantes University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Crohn Disease
- Anal Fistula

## Interventions

- **DRUG:** Alofisel
- **DRUG:** Fat stem cell

## Key facts

- **NCT ID:** NCT05974280
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-02
- **Primary completion:** 2025-01-02
- **Final completion:** 2025-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05974280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05974280, "Study on the Treatment of Anal Fistulas Using Alofisel Versus Fat Autologous Stem Cells". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05974280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*